共 21 条
- [1] Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS272, DOI [10.1111/bph.13877, 10.1111/bph.13882]
- [2] THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 : S130 - S159Alexander, Stephen P. H.Peters, John A.Kelly, EamonnMarrion, Neil V.Faccenda, ElenaHarding, Simon D.Pawson, Adam J.Sharman, Joanna L.Southan, ChristopherDavies, Jamie A.
- [3] THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 : S17 - S129Alexander, Stephen P. H.Christopoulos, ArthurDavenport, Anthony P.Kelly, EamonnMarrion, Neil V.Peters, John A.Faccenda, ElenaHarding, Simon D.Pawson, Adam J.Sharman, Joanna L.Southan, ChristopherDavies, Jamie A.
- [4] (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray[J]. NEUROPHARMACOLOGY, 2018, 139 : 1 - 12Chou, DylanPeng, Hsien-YuLin, Tzer-BinLai, Cheng-YuanHsieh, Ming-ChunWen, Yang-ChengLee, An-ShengWang, Hsueh-HsiaoYang, Po-ShengChen, Gin-DenHo, Yu-Cheng
- [5] Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (01) : 297 - 302Fukumoto, KenichiFogaca, Manoela V.Liu, Rong-JianDuman, CatharineKato, TaroLi, Xiao-YuanDuman, Ronald S.
- [6] The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY[J]. NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) : D1091 - D1106Harding, Simon D.Sharman, Joanna L.Faccenda, ElenaSouthan, ChrisPawson, Adam J.Ireland, SamGray, Alasdair J. G.Bruce, LiamAlexander, Stephen P. H.Anderton, StephenBryant, ClareDavenport, Anthony P.Doerig, ChristianFabbro, DorianoLevi-Schaffer, FrancescaSpedding, MichaelDavies, Jamie A.
- [7] Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine[J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (01) : 12 - 24Highland, Jaclyn N.Morris, Patrick J.Zanos, PanosLovett, JacquelineGhosh, SoumitaWang, Amy Q.Zarate, Carlos A., Jr.Thomas, Craig J.Moaddel, RuinGould, Todd D.
- [8] A Brief History of the Development of Antidepressant Drugs: From Monoamines to Glutamate[J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2015, 23 (01) : 1 - 21Hillhouse, Todd M.Porter, Joseph H.
- [9] Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (11) : 5160 - 5169Lumsden, Eric W.Troppoli, Timothy A.Myers, Scott J.Zanos, PanosAracava, YascoKehr, JanLovett, JacquelineKim, SukhanWang, Fu-HuaSchmidt, StaffanJenne, Carleigh E.Yuan, PeixiongMorris, Patrick J.Thomas, Craig J.Zarate, Carlos A., Jr.Moaddel, RuinTraynelis, Stephen F.Pereira, Edna F. R.Thompson, Scott M.Albuquerque, Edson X.Gould, Todd D.
- [10] Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine[J]. NEUROPHARMACOLOGY, 2019, 153 : 73 - 81Shaffer, Christopher L.Dutra, Jason K.Tseng, Wei ChouWeber, Mark L.Bogart, Luke J.Hales, KatherinePang, JinchengVolfson, DmitriEnde, Christopher W. AmGreen, Michael E.Buhl, Derek L.